Page results
-
The department of medical physics and biomedical engineering provides expert physical science support to activities both within UCLH and to a wide range of external partners.
-
What is Cognitive Behavioural Therapy (CBT)? CBT is evidence-based therapy. It involves working with a practitioner collaboratively, to understand the problems that are keeping you stuck, and to…
-
Media statement UCLH chief executive David Probert said: “Many congratulations to Carrie and Boris Johnson on the birth of their baby daughter Romy Iris Charlotte Johnson. We wish…
-
The Secretary of State for Health and Social Care Sajid Javid visited the UCLH vaccination centre at UCL’s Bidborough House on Thursday 23 September to see the vital role UCLH and UCL are playing in getting the UK’s population vaccinated for COVID-19.
-
The resources for clinicians and patients are to support easier conversations about Parkinson’s dementia.
-
Prime Minister Boris Johnson came to the UCLH vaccination centre based at The Francis Crick Institute to receive his second COVID-19 vaccination.
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
Infection inpatients offers a variety of different specialities including Infectious Diseases and Tropical Medicine, Respiratory Medicine and Rheumatology. We are also the inpatient ward to the Hospital of Tropical Diseases.
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
We want to make you aware that our children and young people’s teams will be available throughout the holiday period to provide advice and support when needed.
File results
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013